310 Results (Page 11 of 13)
Italy Markets Research Reports
Italy Fertility service Market Analysis
Italy Fertility service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Fertility Services is expanding as a result of increasing prevalence of late pregnancy and rising fertility tourism. Advancements in assisted reproductive technology and growing awareness and acceptance are also driving the growth of fertility service market globally. Some of the key players in the global Fertility Service Market are Instituto Bernab?u Group, INVO Bioscience, Inc., Monash IVF Group, Apollo Hospitals Enterprise Ltd., CARE Fertility Group Ltd., Carolinas Fertility Institute, Genea Limited, The Cooper Companies, Inc., Virtus Health Group, Vitrolife Sweden AB, The Johns Hopkins Health System Corporation, Medicover AB (publ), OvaScience, Inc., Progyny, Inc., and Xytex Corporation.
Italy Gene Editing Market Analysis
Italy Gene Editing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Gene Editing is expanding as a result of rising demand for synthetic genes in both developed and developing nations. This demand is fueling the development of better devices and methods for the gene editing. Some of the key players in the global gene editing Market include Addgene, Allele Biotech, Bio-Rad, Takara Bio, CRISPR Therapeutics, OriGene Technologies, Precision Biosciences, GE Healthcare, Merck KGaA, and ThermoFischer Scientific Inc.
Italy Genomics Market Analysis
Italy Genomics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Genomics is expanding as a result of rising incidence of cancer and increased government support. This demand is fueling the development of Genomics and its application in various fields of healthcare. Some of the key players in the global Genomics Market include Aglient Technologies, Illumina, Inc., Danaher Corporation, Hoffmann-La Roche Ltd., QIAGEN, Perkin Elmer, Thermo Fisher Scientific, Eurofins Scientific, Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies Ltd., Myriad Genetic, Pacific Biosciences, and BGI.
Italy Bispecific Antibody Market Analysis
Italy Bispecific Antibody Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Bispecific Antibody is expanding as a result of the increasing prevalence of cancer and auto-immune diseases. This demand is fueling the development of novel bispecific antibody formats and technologies. Some of the key players in the global Bispecific Antibody Market include Roche Holding AG, Amgen Inc., Genentech, Inc., Regeneron Pharmaceuticals, Inc., Merus N.V., Xencor, Inc., Bristol-Myers Squibb Company, Novartis AG, Teneobio, Inc., and MacroGenics, Inc.
Italy Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The Italy Primary Hyperoxaluria (PH) Therapeutics Market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 4.3 % from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is advancement in technology, aging population. The market is segmented by diagnostic method, by treatment, and by type. Some key players in this market are Dicerna Pharmaceuticals, OxThera, Allena Pharmaceuticals, and Recordati Rare Diseases, among others.
Italy Medical Devices Market Analysis
This report presents a strategic analysis of the Italy Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Italy Medical Devices Market, offering unmatched value, accuracy and expert insights.
Italy Home Healthcare Market Analysis
Italy's home healthcare market was valued at $8.70 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.43% from 2022 to 2030 and will reach $15.44 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and an increase in elderly people. The market is segmented by equipment outlook and by services. Some key players in this market are Medyca, Vivisol Srl, Medical Dimension, and Aster.
Italy Dental Care Market Analysis
Italy's dental care market size was valued at $0.6 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.25% from 2022 to 2030 and will reach $1.36 Bn in 2030. This growth is expected to be driven by factors such as the increasing prevalence of dental problems, the growing demand for cosmetic dentistry procedures, and the adoption of advanced dental technologies. The market is segmented by Product Type, By Age Group, By Sales Channel, and End User. Italy’s major dental care players are 3M, A-Dec Inc., Biolase Inc., Carestream Health Inc., and Others.
Italy Electronic Records Management Solutions Market Analysis
Italy's electronic records management solutions market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by solution and deployment. This market will grow as the growing number of firms are aiming to digitize their record management systems in order to increase productivity, cut costs, and enhance security. The key market players are DocuWare, Microsoft Corporation, IBM Corporation, OpenText CorporationM Corporation, OpenText Corporation, Microsoft Corporation, Oracle Corporation, Hyland Software, Inc, and others.
Italy 3D Imaging Market Analysis
Italy's 3D imaging market is projected to grow from $0.73 Bn in 2022 to $2.39 Bn by 2030, registering a CAGR of 16% during the forecast period of 2022-30. The market will be driven by accessibility to 3D imaging solutions and government-established programs to assist the development and use of 3D technology applications. The market is segmented by product, application, end-user & by portability. Some of the major players include Philips Healthcare, Siemens Healthineers & GE Healthcare
Italy Clinical Diagnostics Market Analysis
Italy's clinical diagnostic market was valued at $1.65 Bn in 2022 and is estimated to expand at a CAGR of 5.5% from 2022-30 and will reach $2.53 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in technology and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux, Sysmex, Giesse Diagnostics Srl, Diagnostic Center NSL Italy, Sentinel Diagnostics, DiaSorin, Menarini Diagnostics, Epitech Group and others.
Italy 3D Printing Medical Devices Market Analysis
Italy's 3D printing medical devices market size was valued at $71 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 15.8% from 2022 to 2030 and will reach $230 Mn in 2030. The market is segmented by component, application, technology, and end user. The Italy 3D Printing Medical Devices market will grow 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include 3D-Side, EGO3D, Mecuris Italia, MT Ortho, REJOINT, Storm Line, WASP MED, and others.
Italy Depression Therapeutics Market Analysis
The Italy depression therapeutics market is expected to witness growth from $242 Mn in 2022 to $350 Mn in 2030 with a CAGR of 4.7% for the forecasted year 2022-2030. The rising incidence of depression in Italy and the growing demand for novel therapeutics are responsible for the growth of the market. The Italy depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Procos, Indena, and Cipla are the major players in the Italy depression therapeutics market.
Italy Biomaterials in Healthcare Market Analysis
The Italy Biomaterials Healthcare Market is expected to witness growth from $3.75 Bn in 2022 to $9.75 Bn in 2030 with a CAGR of 12.70% for the forecasted year 2022-2030. The prevalence of persistent illnesses like diabetes, cancer, and cardiovascular disease is increasing in Italy. which fuels the demand for biomaterials in the healthcare sector in Italy. As a consequence, the biomaterials healthcare market in Italy is growing. The market is segmented by type and by application. Some key players in this market include Finceramica Faenza, Lima Corporate, Serbios, BASF SE, Celanese, and Evonik Industries.
Italy Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Italy Lung Cancer Therapeutics Market will reach a value of $1286 Mn from $715 Mn in 2022, growing at a CAGR of 7.6% during 2022-2030. The Lung Cancer Therapeutics Market in Italy is dominated by a few domestic pharmaceutical companies such as Menarini, Chiesi, and MolMed. The Lung Cancer Therapeutics Market in Italy is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Italy lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Italy Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Italy Oncology Therapeutics Market will reach a value of $8 Bn from $4.3 Bn in 2022, growing at a CAGR of 7.9% during 2022-2030. The Oncology Therapeutics Market in Italy is dominated by a few domestic pharmaceutical companies such as Dompe, MolMed, and Menarini. The Oncology Therapeutics Market in Italy is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Italy Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Italy Diabetes Devices Market Analysis
The Italy Diabetes Devices Market is expected to witness growth from $546 Mn in 2022 to $916 Mn in 2030 with a CAGR of 6.70% for the forecasted year 2022-2030. In Italy, the number of cases of diabetes has been gradually rising in recent years. The market for diabetes devices and associated goods will increase as a result of this trend. The market is segmented by type and by the end user. Some key players in this market include Ormesa S.R.L, Angelantoni Life Science, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Italy Anti Aging Therapeutics Market Analysis
Italy anti-aging therapeutics market is expected to witness growth from $14 Mn in 2022 to $48 Mn in 2030 with a CAGR of 16.03% for the year 2022-2030. The rising awareness about age-related disorders among the Italian population and growing investments in anti-aging treatments in Italy by major biotechnology companies are driving the growth of the market. The Italy anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Recipharm, Italfarmaco, and Cambrian Biopharma are among the leading players in the market.
Italy Healthcare Insurance Market Analysis
The Italy healthcare insurance market is projected to grow from $48.63 Bn in 2022 to $84.18 Bn by 2030, registering a CAGR of 7.1% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing chronic disease prevalence, regulatory changes, private insurance market growth and technological advances. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include Generali, Intesa Sanpaolo Vita, Poste Vita, Unipol and Cattolica.
Italy Healthcare Financial Analytics Market Analysis
The Italy Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. Italy’s Healthcare Financial Analytics market will grow as the demand for data-driven decision-making is rising, and financial analytics. The key market players are IBM Watson Health, Zucchetti Group, Optum Italia, Oracle Italia, SAS Institute Italiaand others.
Italy ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Italy's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $709 Mn in 2022 to $1,219 Mn in 2030 with a CAGR of 7% for the year 2022-30. Increasing prevalence and the rise in demand for treatment options for ADHD in Italy are likely the growth drivers for the market expansion. The Italy ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Farmaka, Medac Pharma, and Alcobra are the key players in the market.
Italy Oncology Clinical Trials Market Analysis
Italy's oncology clinical trials market is projected to grow from $303.6 Mn in 2022 to $448.6 Mn by 2030, registering a CAGR of 5% during the forecast period of 2022-30. The market will be driven by the rising incidence of cancer in Italy & well-established research infrastructure and regulatory environment. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG & MolMed S.p.A.
Italy Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Italy Liver Disease Therapeutics market will reach a value of $831 Mn from $554 Mn in 2022, growing at a CAGR of 5.2% during 2022-2030. Liver Disease Therapeutics in Italy is dominated by a few domestic pharmaceutical companies such as Esaote, Chiesi Group, and Dompé. The Liver Disease Therapeutics market in Italy is segmented into different types of disease and different therapy types. Some of the major factors affecting the Italy Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Italy Diabetes Drugs Market Analysis
The Italy diabetes drugs market size was valued at $1.48 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030 and will reach $2.29 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Italy diabetes drug market will grow because, the Italian government has implemented a range of initiatives aimed at improving diabetes management and reducing the burden of the disease on the healthcare system. The key market players are Chiesi Farmaceutici (ITA), Menarini Group (ITA), Boehringer Ingelheim, Sanofi, Boehringer Ingelheim and others.
Italy Neurology Clinical Trials Market Analysis
The Italy Neurology Clinical Trials market is projected to grow from $125.5 Mn in 2022 to $185.5 Mn by 2030, registering a CAGR of 5% during the forecast period of 2022 - 2030. The market will be driven by the rising demand for novel therapies for neurological disorders and the supportive regulatory climate in Italy. The market is segmented by phase, by study design & by indication. Some of the major players include AstraZeneca, Chiesi Farmaceutici & Menarini.
